A.forall Announces First US Launch with Coveted Competitive Generic Therapy (CGT) Exclusivity of Tromethamine Injection 18GM/500mL
A.forall announced through its U.S. subsidiary, Milla Pharmaceuticals Inc., that it has received Abbreviated New Drug Application (ANDA) approval by the U.S. Food and Drug Administration (FDA) for a ...
pharmaphorum9y
Hospira launches RA biosimilar in Western Europe as Remicade patent expires
The first biosimilar monoclonal antibody (mAb), Inflectra (infliximab), has been launched in major European markets by Hospira. The treatment received a positive opinion from the European ...
Morningstar7d
A.forall Announces First US Launch with Coveted Competitive Generic Therapy (CGT) Exclusivity of Tromethamine Injection 18GM/500mL
for a generic version of THAM Solution Tromethamine Injection 18GM/500mL marketed by Hospira Inc, a Pfizer company. Tromethamine Injection is indicated for prevention and correction of metabolic ...
News Medical7d
Plum A+ Infusion System from Hospira
The scalable platform can be initially deployed, and later upgraded to include Hospira MedNet™ safety software to meet your evolving patient care needs. The unique, innovative PlumSet ...
Pharmabiz16d
Glenmark launches phytonadione injectable emulsion USP, 10 mg/mL single dose ampules
Glenmark launches phytonadione injectable emulsion USP, 10 mg/mL single dose ampules: Our Bureau, Mumbai Tuesday, January 21, 2025, 12:15 Hrs [IST] Glenmark Pharmaceuticals Inc., ...